20.07.2022: The recently published update of WHO’s analyses of the global clinical antibacterial pipeline, now integrated within the Global AMR R&D Hub’s Dynamic Dashboard, again highlights a major gap in the development of needed new innovative antibiotics to address growing public health needs globally. Click to find out more.
04.02.2025
New Publication in Vaccine
Vaccines play a vital role in preventing infections and reducing antibiotic use, making them essential tools in the fight against antimicrobial resistance (AMR). Given that AMR disproportionately impacts Low- and Middle-Income Countries (LMICs), this study provides this first comprehensive analysis of global investments in bacterial vaccine research and development (R&D) in LMICs.